Syphilis remains an important cause of uveitis. After reaching a peak annual incidence in the United States of 20.3 cases per 100,000 population in 1990, rates of primary and secondary syphilis declined over the ensuing decade to a record low of 2.1 cases per 100,000 population in 2000, an 89.7% decrease. Despite efforts by the Centers for Disease Control and Prevention to eradicate syphilis, there has been an increase in primary and secondary syphilis rates over the past decade, reaching 4.5 cases per 100,000 population in 2010. 1 In recent years, younger men and men having sex with men have accounted for an increasing number of syphilis cases in the United States. 2 The incidence of syphilis has increased in other countries over the past decade as well. 3,4 Retrospective reviews from large centers have shown that syphilis is the cause of 1.1% to 4.3% of uveitis referrals. 5-7 Although rare, the protean ocular manifestations of syphilis, the potential systemic consequences of untreated syphilis, and the ability to render a long-term cure with antibiotic treatment increase the importance to appropriately test our patients for this disease.The diagnosis of ocular syphilis remains challenging as it can mimic other infectious and noninfectious conditions and the causative organism, Treponema pallidum is not easily recovered in culture. Serology is the method of choice for diagnosing syphilis. Both nontreponemal (eg, venereal disease research laboratory, rapid plasma reagin) and treponemal (eg, T. pallidum particle agglutination, fluorescent treponemal antibody) assays are used. Nontreponemal assays detect antibodies to cardiolipin, are not specific to T. pallidum, and seroconvert to negative after treatment. Treponemal assays detect antibodies to Treponema species and remain reactive for years after adequate therapy. Although